Market Updates

GOED Publishes Report on EPA and DHA’s Impact on Brain Health

The report was created through the use of the organization’s clinical study database, which organizes all clinical studies related to omega-3s.

The Global Organization for EPA and DHA Omega-3s (GOED) recently published a report with an overview of the latest studies on EPA and DHA omega-3s, and the effects they have on specific outcomes related to brain health. The report is available at no cost to GOED members, and is available to non-members for $199.
 
The topic of brain health is of interest to GOED members and the industry, and the report aims to provide insights into the current state of the science, research gaps, and potential directions for future innovations.
 
The report covers the breadth and scope of studies on cognitive health, stress, anxiety, mood, depression, Alzheimer’s disease, ADHD, and more.  
 
The report was created with the help of GOED’s Clinical Study Database (CSD), a tool developed and maintained by GOED to compile and organize all human clinical studies related to EPA and DHA.
 
“Leveraging the immense capabilities of our CSD, GOED was able to streamline the process of data collection and analysis,” said Kaitlin Roke, PhD, director of scientific communication and outreach at GOED. “We calculated that by using the Clinical Study Database to put this report together, we saved approximately 30 hours of work compared to employing a traditional academic search strategy.”
 

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Related Breaking News